Positron Corp is a medical technology company engaged in the development, manufacturing, and sales of PET and PET-CT molecular imaging systems for nuclear medicine providers across North America... Show more
POSC saw its Momentum Indicator move above the 0 level on September 24, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 133 similar instances where the indicator turned positive. In of the 133 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for POSC just turned positive on September 25, 2025. Looking at past instances where POSC's MACD turned positive, the stock continued to rise in of 69 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where POSC advanced for three days, in of 97 cases, the price rose further within the following month. The odds of a continued upward trend are .
POSC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where POSC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
POSC moved below its 50-day moving average on September 16, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for POSC crossed bearishly below the 50-day moving average on September 04, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 24 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where POSC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for POSC entered a downward trend on September 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (60.328). P/E Ratio (0.087) is within average values for comparable stocks, (37.225). POSC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.677). POSC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (0.242) is also within normal values, averaging (79.566).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. POSC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry MedicalNursingServices
A.I.dvisor tells us that POSC and SLDX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POSC and SLDX's prices will move in lockstep.
Ticker / NAME | Correlation To POSC | 1D Price Change % | ||
---|---|---|---|---|
POSC | 100% | +2.58% | ||
SLDX - POSC | 27% Poorly correlated | N/A | ||
GMED - POSC | 20% Poorly correlated | -0.36% | ||
RSMDF - POSC | 9% Poorly correlated | +6.60% | ||
RSCF - POSC | 8% Poorly correlated | -11.75% | ||
PFGTF - POSC | 7% Poorly correlated | N/A | ||
More |
Ticker / NAME | Correlation To POSC | 1D Price Change % |
---|---|---|
POSC | 100% | +2.58% |
Medical/Nursing Services industry (225 stocks) | 6% Poorly correlated | -0.10% |
Health Services industry (437 stocks) | 3% Poorly correlated | -0.02% |